These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22428083)

  • 1. Incentives and barriers to neurological clinical research participation.
    Lindblad AS; Zingeser P; Sismanyazici-Navaie N
    Clin Investig (Lond); 2011 Dec; 1(12):1663-1668. PubMed ID: 22428083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
    Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
    Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.
    Melisko ME; Hassin F; Metzroth L; Moore DH; Brown B; Patel K; Rugo HS; Tripathy D
    Clin Breast Cancer; 2005 Apr; 6(1):45-54. PubMed ID: 15899072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public attitudes regarding willingness to participate in medical research studies.
    Trauth JM; Musa D; Siminoff L; Jewell IK; Ricci E
    J Health Soc Policy; 2000; 12(2):23-43. PubMed ID: 11184441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists.
    Siminoff LA; Zhang A; Colabianchi N; Sturm CM; Shen Q
    J Clin Oncol; 2000 Mar; 18(6):1203-11. PubMed ID: 10715289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organizational barriers to physician participation in cancer clinical trials.
    Somkin CP; Altschuler A; Ackerson L; Geiger AM; Greene SM; Mouchawar J; Holup J; Fehrenbacher L; Nelson A; Glass A; Polikoff J; Tishler S; Schmidt C; Field T; Wagner E
    Am J Manag Care; 2005 Jul; 11(7):413-21. PubMed ID: 16044978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to participation in clinical trials: a physician survey.
    Mahmud A; Zalay O; Springer A; Arts K; Eisenhauer E
    Curr Oncol; 2018 Apr; 25(2):119-125. PubMed ID: 29719427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing a Memory Clinic Model to Facilitate Recruitment into Early Phase Clinical Trials for Mild Cognitive Impairment and Alzheimer's Disease.
    Park L; Kouhanim C; Lee S; Mendoza Z; Patrick K; Gertsik L; Aguilar C; Gullaba D; Semenova S; Jhee S
    J Prev Alzheimers Dis; 2019; 6(2):135-138. PubMed ID: 30756120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do - or don't - patients with urinary tract infection participate in a clinical trial? A qualitative study in German family medicine.
    Bleidorn J; Bucak S; Gágyor I; Hummers-Pradier E; Dierks ML
    Ger Med Sci; 2015; 13():Doc17. PubMed ID: 26512232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) Initiative.
    Pinto HA; McCaskill-Stevens W; Wolfe P; Marcus AC
    Ann Epidemiol; 2000 Nov; 10(8 Suppl):S78-84. PubMed ID: 11189096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of physician referral for patient recruitment to Alzheimer disease clinical trials.
    Galvin JE; Meuser TM; Boise L; Connell CM
    Alzheimer Dis Assoc Disord; 2009; 23(4):352-6. PubMed ID: 19561438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study.
    Lalu MM; Foster M; Presseau J; Dowlatshahi D; Castillo G; Cardenas A; Tam W; Zlepnig J; Timpson D; Dong YY; Juneau P; Fergusson DA
    BMJ Open; 2020 Mar; 10(3):e034354. PubMed ID: 32198301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
    Townsley CA; Chan KK; Pond GR; Marquez C; Siu LL; Straus SE
    BMC Cancer; 2006 Feb; 6():34. PubMed ID: 16466574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care physicians' perceptions of barriers to genetic testing and their willingness to participate in research.
    Mountcastle-Shah E; Holtzman NA
    Am J Med Genet; 2000 Oct; 94(5):409-16. PubMed ID: 11050628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived Barriers to Clinical Trials Participation: A Survey of Pediatric Caregivers.
    Sollo N; Ahlers-Schmidt CR; Davis AM; Smith TR; Dedeaux JA; McCulloh RJ
    Kans J Med; 2022; 15():139-143. PubMed ID: 35646248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fostering participation of general practitioners in integrated health services networks: incentives, barriers, and guidelines.
    de Stampa M; Vedel I; Bergman H; Novella JL; Lapointe L
    BMC Health Serv Res; 2009 Mar; 9():48. PubMed ID: 19292905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to participation in surgical randomized controlled trials in pediatric urology: A qualitative study of key stakeholder perspectives.
    Vemulakonda VM; Jones J
    J Pediatr Urol; 2016 Jun; 12(3):180.e1-7. PubMed ID: 26455638
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.